跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Renite XL - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Renite XL
Approved
STANDARD
Renite XL
XL Laboratories Pvt Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5604fa2408154449
Company
XL Laboratories Pvt Ltd
Type
Standard
Approval Details
Approval Id
5604fa2408154449
Drug Approval Philippines Name
Renite XL
Product Name
Renite XL
Registration Number
DRP-2322
Brand Name
Renite XL
Generic Name
Enalapril Maleate
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
XL Laboratories Pvt Ltd
Importer
Ambica International Trading Corporation
Distributor
Ambica International Trading Corporation
Issuance Date
29 February 2024
Expiry Date
01 December 2029
Pharmacologic Category
Angiotensin Converting Enzyme (ACE) Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5604fa2408154449
Type
Standard
Back to Philippines FDA Approvals